Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
William Harris Investors (WHI) is a Chicago-based family office and investment management firm that manages the wealth of the Irving Harris family and other high-net-worth clients. The firm is a significant investor in the life sciences and healthcare sectors, providing venture capital and private equity to companies developing innovative therapeutics, medical devices, and healthcare IT solutions. WHI is known for its long-term investment horizon and its role in supporting the growth of numerous successful biotech startups from early stages through acquisition or public offering. The firm's investment strategy emphasizes capital preservation and growth through a diversified portfolio of public and private assets. WHI maintains a dedicated team of professionals focused on identifying breakthrough scientific advancements in the healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on William Harris Investors.